450 results on '"Kraft, Andrew S."'
Search Results
2. Synthesis of 2-oxoquinoline derivatives as dual pim and mTORC protein kinase inhibitors
3. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth
4. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
5. Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report
6. Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death
7. The Human brm Protein Is Cleaved during Apoptosis: The Role of Cathepsin G
8. Conditional Expression of Mitogen-Activated Protein Kinase Phosphatase-1, MKP-1, is Cytoprotective against UV-Induced Apoptosis
9. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion
10. Table S11-14 from PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
11. Data from PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
12. Data from PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
13. Table S2-3 from PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
14. Supplementary Data from p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
15. Supplementary Appendix file from PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
16. Supplementary Methods and Figures S1-S4 from Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
17. Table S4-5 from PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
18. Supplemental Figures 1-3 from PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
19. Figure S5 from Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
20. Supplementary Data from Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response
21. Figure legends from Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
22. Supplementary Fig. S2 from Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3′-untranslated region
23. Supplementary Table S1 from Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3′-untranslated region
24. Supplementary Data from Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
25. Data from The BH3 Mimetic ABT-737 Induces Cancer Cell Senescence
26. Data from Pim Kinase Inhibitors Sensitize Prostate Cancer Cells to Apoptosis Triggered by Bcl-2 Family Inhibitor ABT-737
27. Supplementary Figure 6 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
28. Data from Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1
29. Supplementary Figure 1 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
30. Data from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
31. Data from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
32. Supplementary Methods, Figures 1-7 from Pim Kinase Inhibitors Sensitize Prostate Cancer Cells to Apoptosis Triggered by Bcl-2 Family Inhibitor ABT-737
33. Data from Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors
34. Supplementary Figures 1 - 3 from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
35. Supplementary Methods and Figure legends from Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
36. Supplementary Methods, Figures 1 - 9 from Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1
37. Supplementary Methods, Figures 1-8, Table 1 from The BH3 Mimetic ABT-737 Induces Cancer Cell Senescence
38. Supplementary Methods from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
39. Supplementary Table 1 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
40. Supplementary Figure 5 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
41. Supplementary Figure 3 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
42. Supplementary Figure 4 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
43. Supplementary Figure 2 from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
44. Supplementary Figure Legend from Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
45. An XBP1s–PIM-2 positive feedback loop controls IL-15–mediated survival of natural killer cells
46. OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma
47. Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate Adenocarcinoma
48. Bax-Induced Apoptotic Cell Death
49. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
50. The Pim protein kinases regulate energy metabolism and cell growth
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.